Literature DB >> 25818711

Knowing the speed limit: weighing the benefits and risks of rehabilitation progression after arthroscopic rotator cuff repair.

Charles A Thigpen1, Michael A Shaffer2, Michael J Kissenberth3.   

Abstract

Rotator cuff repairs have increased. Although clinical trials have examined the effect of immobilization and timing of passive range of motion (ROM) on patient outcomes and structural integrity, there is controversy as to the timing and progression for therapy. Primary goals are restoring function while maintaining the structural integrity of the repair. We advocate for a protocol of 4 to 6 weeks of immobilization, followed by protected passive ROM, which is followed by a gradual progression to active ROM and then appropriate resistance exercise program for most all rotator cuff repairs. The rate of progression should be adjusted individually.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Outcomes; Range of motion; Rehabilitation; Rotator cuff repair

Mesh:

Year:  2015        PMID: 25818711     DOI: 10.1016/j.csm.2014.12.007

Source DB:  PubMed          Journal:  Clin Sports Med        ISSN: 0278-5919            Impact factor:   2.182


  3 in total

Review 1.  Rotator cuff tears: An evidence based approach.

Authors:  Senthil Nathan Sambandam; Vishesh Khanna; Arif Gul; Varatharaj Mounasamy
Journal:  World J Orthop       Date:  2015-12-18

2.  Early rehabilitation affects functional outcomes and activities of daily living after arthroscopic rotator cuff repair: a case report.

Authors:  Satoshi Shimo; Yuta Sakamoto; Akinari Tokiyoshi; Yasuhiro Yamamoto
Journal:  J Phys Ther Sci       Date:  2016-02-29

3.  Conservative versus accelerated rehabilitation after rotator cuff repair: a systematic review and meta-analysis.

Authors:  Umile Giuseppe Longo; Laura Risi Ambrogioni; Alessandra Berton; Vincenzo Candela; Filippo Migliorini; Arianna Carnevale; Emiliano Schena; Ara Nazarian; Joseph DeAngelis; Vincenzo Denaro
Journal:  BMC Musculoskelet Disord       Date:  2021-07-24       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.